Ian Poburenny
Director
Rothschild & Co
Ian is a Director at Rothschild & Co focusing on healthcare services and nuclear medicine. Based in London, he advises investors, corporates and business owners on M&A, IPO and financing transactions across Europe, the US and the Middle East. He recently advised on the sale of Medivet, Ergea, Sanoptis, PharmaLogic, Curium and Priory
Hear me speak on
![](https://www.healthcarebusinessinternational.com/events/wp-content/uploads/sites/2/Ian-Poburenny.jpg)
![](https://www.healthcarebusinessinternational.com/events/wp-content/uploads/sites/2/Ian-Poburenny.jpg)
For more amazing speakers
HBI 2024 will be full of amazing people like this. See who else will be speaking.
![](https://www.healthcarebusinessinternational.com/events/wp-content/uploads/sites/2/Speakers-widget.png)